From April 1, 2024 to June 30, 2024, the company has repurchased 512,888 shares, representing 0.58% for CNY 16.99 million. With this, the company has completed the repurchase of 2,129,043 shares, representing 2.36% for CNY 87.42 million under the buyback announced on December 9, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
29.62 CNY | -4.85% |
|
-0.37% | -46.63% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-46.63% | 362M | |
+22.15% | 46.56B | |
+45.09% | 41.67B | |
-2.37% | 41.16B | |
+33.84% | 32.4B | |
-6.35% | 28.1B | |
+20.42% | 28.18B | |
+48.83% | 14.52B | |
+45.00% | 13.74B | |
+0.06% | 12.17B |
- Stock Market
- Equities
- 688073 Stock
- News Bide Pharmatech Co., Ltd.
- Tranche Update on Bide Pharmatech Co., Ltd.'s Equity Buyback Plan announced on December 9, 2023.